Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of Ultrasound-Guided Percutaneous Neuromodulation on the Strength of CrossFit Athletes

NCT06529770 is registered in ClinicalTrials.gov with Universidad de Zaragoza as lead sponsor.

NCT NCT06529770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06529770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of Ultrasound-Guided Percutaneous Neuromodulation on the Strength of CrossFit Athletes
Lead sponsor
Universidad de Zaragoza
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2024
Completion date
December 13, 2024
Enrollment
39 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crossfit, healthy